UCSF is one site of an NIMH-funded multi-site, international efficacy trial of a behavioral intervention to reduce the incidence of HIV infection. Collaborating international sites teamed with US sites are: Zimbabwe (S. Morin, UCSF PI), South Africa (T. Coates, UCLA PI), Tanzania (M. Sweat, Johns Hopkins University PI) and Thailand (D. Celantano, Johns Hopkins University PI).
This project is an extension of the International Traineeships in AIDS Prevention Studies Program (I-TAPS) through a partnership with the Centro de Estudos de AIDS do Rio Grande do Sul (CEARGS) in Porto Alegre, Brazil and with the Universidade Federale do Bahia (UFBA) in Salvador, and funded by the Fogarty International Center.
This study tests the efficacy of an intervention utilizing HIV rapid testing and integration of HIV Voluntary Counseling and Testing (VCT) into Tuberculosis (TB) evaluation and home-based VCT for family members, to overcome identified logistical and psychological barriers to HIV VCT among new TB patients and their family members.
The specific aims of the study are:
To determine the uptake of and barriers to HIV VCT among a cross-sectional sample of 2,000 TB evaluation patients offere
This project is designed to provide information that will be critical to the performance of a pivotal RCT of screening and treatment of anal intraepithelial neoplasia (AIN) to prevent anal cancer. This project will study determinants of participation in an RCT in which 50% of participants with AIN will be screened and treated, and 50% will be observed without treatment. At the end of a 5-year period, the number of anal cancer cases will be compared in both arms.
Drug and alcohol use is not always addressed with patients in medical care settings, including HIV primary care settings. The screening, brief intervention, and referral to treatment (SBIRT) strategy has demonstrated an effective model to introduce screening for substance use, and standardized guidelines in a number of clinical populations, but SBIRT for drug and alcohol use has not been tested in an HIV primary care setting.
I-TRIP studies sexual risk behavior in the context of international travel among gay and bisexual men from the San Francisco Bay Area. The specific aims are: To measure the prevalence of sexual risk behavior during international travel among gay and bisexual men from the Bay Area. To document the prevalence of ART drug resistance among gay and bisexual international travelers from the Bay Area.
Internal and external coalition functioning is an important predictor of coalition success that has been linked to perceived coalition effectiveness, coalition goal achievement, coalition ability to support evidence-based programs, and coalition sustainability. Understanding which aspects of coalition functioning best predict coalition success requires the development of valid measures of empirically unique coalition functioning constructs.
This project has two aims: 1
To describe collective and individual belief systems of low-income township men who have sex with men (MSM) related to their sexuality, sexual health, choice of sexual partners, use of drugs and alcohol, use of condoms, utilization of health services, HIV voluntary counseling and testing (VCT) and disclosure of HIV status, in order to describe prevailing cultural norms around these subjects’ behaviors
To assess the prevalence of HIV risk factors
Can HIV testing plus linking HIV+ people to care and treatment reduce HIV transmission?
Why is this an important question?
Despite major progress against HIV, 21% of HIV+ people in the US are unaware that they are positive1 and an estimated 33% of those who know they are HIV+ are not engaged in care and treatment for their infection.2 Another 38% of newly diagnosed HIV+ individuals test so late that they receive an AIDS diagnosis at the same time
Despite major progress against HIV, 21% of HIV+ people in the US are unaware that they are positive and an estimated 33% of those who know they are HIV+ are not engaged in care and treatment for their infection.Another 38% of newly diagnosed HIV+ individuals test so late that they receive an AIDS diagnosis at the same time as, or within one year of, learning they are positive. There were an estimated 56,300 new HIV infections per year between 1996 and 2006.
This research complements improvements in HIV services being developed in San Francisco under the auspices of the CDC’s Enhanced Comprehensive HIV Prevention Planning (ECHPP), and augments ECHPP-related evaluations already being supported through the NIH-supported Centers for AIDS Research.
¿Cómo puede integrarse la prevención del VIH en los establecimientos de atención de salud?
¿Por qué es importante la prevención de la infección por el VIH en los establecimientos de atención de salud?
La prevención de la infección por el VIH es una parte importante de la atención de la salud de todas las personas.
How can HIV prevention be integrated into health care settings?
Why is HIV prevention important in health care settings?
HIV prevention is an important part of health care for all individuals. It is particularly key for those at risk of becoming infected, as well as for those who are already infected, who can then avoid transmitting HIV to others and stay healthy themselves.
How can HIV prevention be integrated into health care settings?
Prepared by Carol Dawson-Rose RN PhD, Janet Myers PhD MPH, and Karen McCready MA; CAPS Fact Sheet 68, July 2010
This toolkit is a “how to” guide for planning and implementing evaluation activities in cancer prevention and control programs.
The Comprehensive Cancer Control Branch (CCCB) is part of the Centers for Disease Control and Prevention’s (CDC’s) Division of Cancer Prevention and Control (DCPC). CCCB developed this toolkit to help funded programs meet the evaluation requirements established for their cooperative agreements.
